Program Code: SCF-DBI-PICU-INFECTION-0001**
Operational Window: PICU Admission → PICU Stay → Step-Down → Discharge
Primary Objective: Prevent hospital-acquired infections (HAIs), preserve immunologic self-tolerance, protect endothelial integrity, reduce antimicrobial burden, and maintain recovery intelligence throughout PICU admission.
SECTION 14.1
CLINICAL POSITIONING
Traditional Infection Prevention Model
Focuses on:
- Hand hygiene
- Central line bundles
- Ventilator bundles
- Environmental cleaning
- Antibiotic stewardship
SCF-DBI Infection Prevention Model
Healthcare-associated infections are viewed as:
Secondary Biological Intelligence Disruption Events
that may induce:
Neuroimmune destabilization
Endothelial injury
Recovery delays
Cognitive impairment
Functional decline
Increased mortality risk
Core Principle
Every preventable infection avoided preserves recovery intelligence and developmental resilience.
SECTION 14.2
RHENOVA INFECTION PREDICTION ENGINE (RIPE)
Strategic Purpose
Predict infection before clinical manifestation.
Core Prediction Domains
Host Risk
Immune competence
STRI
Chronic illness burden
Device Risk
Central lines
Ventilators
Urinary catheters
ECMO
CRRT
Environmental Risk
Unit outbreak activity
Colonization burden
Room contamination history
Recovery Risk
Nutritional status
Mobility limitations
Recovery trajectory
Output
Infection Risk Probability Score (IRPS)
SECTION 14.3
HOSPITAL-ACQUIRED INFECTION (HAI) PREVENTION SOP
Primary Targets
CLABSI
VAE
CAUTI
Surgical site infection
ECMO-associated infection
CRRT-associated infection
Multidrug-resistant organism transmission
Prevention Objectives
Minimize exposure
Preserve immune competence
Reduce invasive device duration
Protect recovery trajectories
SECTION 14.4
CLABSI PREVENTION PROGRAM
Strategic Position
Central lines represent:
Necessary Access with Biologic Intelligence Risk
Insertion Bundle
Maximal sterile barrier precautions
Chlorhexidine-based skin preparation (age-appropriate)
Site optimization
Ultrasound guidance when appropriate
Standardized insertion checklist
Daily Review
Evaluate:
Line necessity
Infection signs
Dressing integrity
Access frequency
Removal Criteria
No longer clinically required
Alternative access available
Infection suspicion
SECTION 14.5
VENTILATOR-ASSOCIATED EVENT (VAE) PREVENTION SOP
Strategic Position
Mechanical ventilation increases risk of:
Infection
Endothelial injury
Recovery delay
Prevention Bundle
Elevation of head of bed
Oral care protocol
Sedation optimization
Daily liberation assessment
Airway secretion management
Monitoring
Respiratory status
Chest imaging
Biomarkers
ANMS
SECTION 14.6
CAUTI PREVENTION FRAMEWORK
Objectives
Reduce:
Catheter duration
Infection burden
Recovery disruption
Daily Assessment
Ongoing necessity
Urine output adequacy
Signs of infection
Removal Priority
Remove at earliest safe opportunity.
SECTION 14.7
SURGICAL SITE INFECTION (SSI) PREVENTION PROGRAM
High-Risk Populations
Trauma surgery
Transplant surgery
Neurosurgery
Cardiothoracic surgery
Major abdominal surgery
Prevention Components
Antibiotic optimization
Glycemic optimization
Perfusion optimization
Wound surveillance
Endothelial preservation
Recovery Monitoring
STRI
EII
Healing trajectory
SECTION 14.8
ECMO & CRRT INFECTION PREVENTION SOP
Strategic Position
Extracorporeal systems create prolonged infection vulnerability.
Surveillance Domains
Circuit infection
Bloodstream infection
Cannulation-site infection
Immune competence
Monitoring Variables
Cultures
Inflammatory markers
STRI
Clinical trajectory
SECTION 14.9
ENVIRONMENTAL MICROBIOME INTELLIGENCE PROGRAM
Clinical Positioning
PICU microbial ecology influences infection risk.
Surveillance Domains
Environmental contamination burden
Outbreak activity
High-touch surface contamination
Device contamination risk
Prevention Components
Cleaning validation
Isolation protocols
Equipment stewardship
Environmental surveillance
SECTION 14.10
RHENOVA IMMUNE RESILIENCE PRESERVATION BUNDLE
Strategic Objective
Maintain host defense while minimizing excessive inflammation.
Core Components
Nutrition optimization
Sleep preservation
Early mobility
Delirium prevention
Immune surveillance
Monitoring
STRI
ANMS
Recovery progression
SECTION 14.11
OUTBREAK DETECTION & CONTAINMENT FRAMEWORK
Trigger Events
Clustered infections
Resistant organism emergence
Unexpected infection increase
Device-associated infection spike
Response Levels
Level 1
Enhanced Surveillance
Level 2
Focused Investigation
Level 3
Containment Activation
Level 4
Unit-Wide Response
SECTION 14.12
INFECTION ANMS FRAMEWORK
Neuroimmune Domain
Monitor:
Infection burden
Inflammatory burden
STRI
Neurocardiac Domain
Monitor:
Perfusion
Shock risk
Neurovascular Domain
Monitor:
Endothelial injury
EII
Neurometabolic Domain
Monitor:
Lactate
Nutritional adaptation
Neuroendocrine Domain
Monitor:
Stress burden
Recovery reserve
SECTION 14.13
INFECTION ESCALATION MATRIX
Level 1
Enhanced Monitoring
Triggers:
Rising inflammatory biomarkers
Early infection concern
Level 2
Focused Investigation
Triggers:
Device infection suspicion
Recovery delay
STRI decline >15%
Level 3
Multidisciplinary Escalation
Triggers:
Confirmed HAI
Organ dysfunction
EII decline >20%
Level 4
Critical Rescue Activation
Triggers:
Septic shock
MODS
ANMS <40
SECTION 14.14
DE-ESCALATION CRITERIA
Clinical
Infection controlled
Stable organ function
No new infection concerns
SCF
Improving STRI
Stable ANMS
Improving EII
Recovery
Positive recovery trajectory
Functional progression
SECTION 14.15
INFECTION PREVENTION ENDPOINTS
Clinical Success
Reduced CLABSI
Reduced VAE
Reduced CAUTI
Reduced SSI
Reduced bloodstream infections
Recovery Success
Reduced ICU LOS
Reduced antibiotic exposure
Reduced recovery delays
Biological Intelligence Success
STRI >80
ANMS >80
EII >80
Sustained recovery progression
PAGE 14 COMPLETION
Next Page (Page 15):